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Abstract
H7 subtype influenza viruses have demonstrated an ocular tropism in humans, causing 
conjunctivitis and not respiratory symptoms in many infected individuals. However, the molecular 
determinants which confer ocular tropism are still poorly understood. Here, we used a murine 
model of ocular inoculation to demonstrate that H7 influenza viruses are more likely to cause 
infection following ocular exposure than are non-H7 subtype viruses. We included investigation 
regarding the potential role of several properties of influenza viruses with murine infectivity 
following ocular inoculation, including virus lineage, pathogenicity, and HA cleavage site 
composition. Furthermore, we examined the potential contribution of internal proteins to murine 
ocular infectivity. These studies establish a link between H7 subtype viruses and the risk of 
heightened infectivity in a mammalian species following ocular exposure, and support the 
development of non-traditional inoculation methods and models to best understand the human risk 
posed by influenza viruses of all subtypes.
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1. Introduction
H7 subtype influenza viruses, with the notable exception of H7N9 viruses, are typically 
associated with ocular complications in humans, with ~80% of reported cases presenting 
with conjunctivitis (Belser et al., 2009a). In contrast, the majority of non-H7 subtype avian 
and human influenza viruses generally present with respiratory symptoms in humans, with 
ocular complications only rarely reported (Belser et al., 2013c). However, the human eye 
and surrounding conjunctiva represent a secondary mucosal surface bearing permissive 
receptors susceptible to virus infection (Kumlin et al., 2008), underscoring that ocular 
exposure to influenza viruses represents a potential route of virus entry for multiple virus 
subtypes. Thus, elucidating how influenza viruses use the eye as a means to establish a 
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respiratory infection, and determining the viral and host features which govern ocular 
tropism, will offer critical information which can guide public health responses during 
outbreaks of H7 subtype virus.
The capacity for influenza viruses to cause disease following ocular exposure has been 
examined in several in vitro and in vivo models. Multiple human ocular cell types (including 
corneal and conjunctival cells) have demonstrated the ability to support productive 
replication of both human and avian influenza viruses (Belser et al., 2011b; Chan et al., 
2010; Michaelis et al., 2009). Similarly, ferrets (challenged with either a liquid or aerosol 
inoculum) have revealed a capacity for both human and avian influenza viruses to use the 
eye as a portal of entry to establish a productive respiratory infection (Aamir et al., 2009; 
Belser et al., 2014, 2012a). In contrast, ocular inoculation of mice has shown that H7 
influenza viruses appear to more frequently infect following inoculation and are detected in 
the eye more often than other virus subtypes (Belser et al., 2009b; Sun et al., 2009; Tannock 
et al., 1985).
Identifying a mammalian model which recapitulates the tropism observed in humans offers 
an opportunity to investigate which features of H7 subtype viruses confer ocular tropism or 
ocular infectivity in vivo. Here, we assess numerous viral properties for their influence on 
murine infectivity following ocular inoculation, including the contribution of surface 
glycoprotein composition, HA cleavage site, lineage, receptor binding preference, and 
internal gene constellation. We find that, in agreement with human epidemiological reports, 
H7 subtype viruses are more likely to cause infection following ocular inoculation in a 
mammalian model, and are more likely than other virus subtypes to replicate within ocular 
tissue, including H5N1 viruses. Identification of properties which do or do not confer ocular 
tropism in a mammalian host provides needed information to more precisely determine the 
molecular correlates which govern this attribute in humans.
2. Methods
2.1. Viruses
Influenza A viruses included in the analyses in this study are shown in Tables 1 and 3, with 
ocular pathotyping data for each virus either published previously (as indicated by the 
presence of a reference in Table 1) or generated for this study. All viruses were propagated 
in the allantoic cavity of 10-day-old embryonating chicken eggs, with the exception of 
pandemic 1918 and 2009 H1N1 viruses, which were propagated in Madin-Darby canine 
kidney (MDCK) cells, as referenced in Table 1. The 50% egg infectious dose (EID50) titer 
for each virus stock was calculated by the method of Reed and Muench (Reed and Muench, 
1938). The PFU titer was determined by standard plaque assay in MDCK cells (Zeng et al., 
2007). All experiments with avian-origin viruses were conducted under biosafety level 3 
containment, including enhancements required by the U.S. Department of Agriculture and 
the Division of Select Agents and Toxins/CDC (Chosewood and Wilson, 2009).
Reassortant viruses were generated by transfecting the reverse genetics plasmids encoding 
the HA and NA surface genes from the virus of interest along with the six internal genes 
from PR8 influenza virus into qualified Vero or 293-T cells (O’Neill and Donis, 2009; 
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Ridenour et al., 2015; Sun et al., 2016b). For hemagglutinin genes derived from H5N1 
highly pathogenic avian influenza virus, including A/Vietnam/1203/2004 and A/Indonesia/
5/2005, overlapping PCR mutagenesis was performed to remove the polybasic amino acids 
(O’Neill and Donis, 2009; World Health Organization Global Influenza Program 
Surveillance, 2005).
2.2. Murine ocular inoculation
Female BALB/c mice (6-to-8 weeks of age) were inoculated by the ocular route as 
previously described (Belser et al., 2009b). Infection was determined by harvesting the eyes 
(pooled), nose, and lungs of mice on days 3 and 6 post-inoculation (p.i.), followed by 
homogenizing, and titrating them in eggs or cells. The limit of detection was 100.8 EID50/ml 
or 10 PFU/ml. Ocular pathotyping data from mice were collected from previously published 
studies (indicated with a reference in Table 1) or generated for this study (indicated as such 
in Table 1, Table 3). All wild-type viruses included in the study have been shown previously 
to infect mice by the intranasal inoculation route without prior adaptation. The dataset 
presented in Table 1 is limited to experiments performed at the Centers for Disease Control 
and Prevention under an Institutional Animal Care and Use Committee-approved protocol to 
minimize experimental variability.
2.3. Statistical analyses
Statistical analyses were performed using R version 3.2.3, including the binom and MRCV 
packages (Dorai-Raj, 2014; Koziol and Bilder, 2014; The R Core Team, 2015). Because 
multiple hypotheses were being tested, two-tailed p values < 0.01 are considered significant 
and 99% confidence intervals are given. Infection frequencies were compared using Fisher’s 
exact or Fisher-Freeman-Halton tests. Data comparing rates of virus detection in different 
tissues between H5 and H7 viruses were tested for simultaneous pairwise marginal 
independence using a modified Pearson chi-square statistic with Bonferroni adjustment as 
previously described (Agresti and Liu, 1999). Hemagglutinin subtype was treated as a 
single-response multiple-choice variable, while the tissues in which virus was detected was 
treated as a multiple-choice multiple response variable. Graphics were generated using 
GraphPad Prism 6 software.
3. Results
3.1. Contribution of surface glycoproteins to ocular infectivity
Influenza viruses of multiple subtypes have been shown to infect mice by the ocular route, 
with select H7 and H5 viruses capable of causing a fatal infection following ocular 
inoculation (Belser et al., 2009b). However, while H7 influenza viruses appear well-suited to 
infect mice by this inoculation route, it was unknown if the presence of an H7 hemagglutinin 
confers an enhanced ability for influenza virus to infect mice following ocular inoculation. 
To ascertain if murine infection following ocular inoculation occurred more frequently for 
viruses bearing an H7 hemagglutinin than for those of other HA subtypes, we examined a 
panel of 34 influenza viruses (Table 1). In this analysis, animals were counted as “infected” 
if infectious virus was detected in any tissue (eye, nose, or lung) above our limit of detection 
on either day 3 or 6 p.i. We found that H7 viruses were 2.8 times as likely to cause infection 
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as were non-H7 viruses (p < 0.001) (Table 2, Fig. 1A). Separating the non-H7 viruses by 
subtype revealed that infection was most frequent after exposure to H5 viruses (41% of mice 
infected), but still lower than for H7 viruses (66% of mice infected, p < 0.001) (Table 2, Fig. 
1B).
The plasticity of the H7 hemagglutinin to accommodate numerous neuraminidase subtypes 
in isolates associated with human infection is a feature not typically observed with other 
hemagglutinins. While ocular complications (with or without respiratory involvement) have 
been reported following human exposure with H7N2, H7N3, and H7N7 viruses, H7N9 
viruses are typically associated with severe respiratory and not ocular disease (Belser et al., 
2009a; To et al., 2014). To examine if the neuraminidase paired with the H7 hemagglutinin 
influences the capacity to cause infection following ocular inoculation in mice, we examined 
the risk of murine infection following inoculation with H7 viruses separated by NA subtype. 
We found that the neuraminidase coupled with the H7 HA did not significantly alter virus 
infectivity in this model, as the three H7 HA-NA combinations most frequently associated 
with human infection (H7N3, H7N7, and H7N9) all possessed infection rates > 75% with no 
significant differences observed among any of them (p=0.73, Fig. 1B; H7N2 and H7N8 were 
excluded from this analysis due to small sample size and lack of diversity among tested 
isolates). Both Eurasian and North American lineage H7 viruses have been associated with 
human infection, whereas human infections with H5N1 viruses have been limited to those 
from the Eurasian lineage. Among these three H7 HA-NA combinations, we did not detect a 
significant difference between North American (H7N3, H7N9) and Eurasian (H7N7, H7N9) 
lineage viruses in the frequency of ocular infection of mice (p=0.41, Fig. 1C). Collectively, 
these analyses indicate that the presence of an H7 hemagglutinin strongly affects the 
frequency of infection following ocular inoculation in the mouse model, regardless of the 
neuraminidase with which it is paired or the lineage from which it is derived.
3.2. Contribution of hemagglutinin cleavage site to ocular infectivity
Avian influenza viruses are classified as either highly pathogenic avian influenza (HPAI) or 
low pathogenic avian influenza (LPAI) viruses based on their virulence in chickens [per the 
Intravenous Pathogenicity Index (IVPI) or chicken lethality tests] or similarity of molecular 
attributes within the HA cleavage site motif to other HPAI viruses (OIE, 2015). While HPAI 
viruses frequently present with enhanced virulence in mammals compared with LPAI 
viruses, this is not always the case; both H7 HPAI and LPAI viruses have been associated 
with severe human infection and ocular disease. In mice, H7 HPAI viruses caused infection 
more frequently than did LPAI viruses (74% vs 59%, respectively), but this difference was 
not statistically significant (Fig. 1D). These results affirm that H7 LPAI and HPAI viruses 
are both capable of causing mammalian infection by the ocular route.
Among H7 viruses, it is not uncommon for a LPAI virus to acquire a HPAI phenotype 
during the course of an outbreak in poultry; examination of both LPAI and HPAI viruses 
sourced from the same outbreak thus permits an opportunity to examine specific molecular 
determinants of pathogenicity that may not be possible among other wild-type viruses. To 
more closely investigate the role of the HA cleavage site in ocular infectivity, we examined 
two pairs of viruses isolated from the same outbreak that emerged via nonhomologous 
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recombination events and differ primarily in their IVPI classification and cleavage site. The 
H7N3 viruses A/Canada/504/2004 and A/Canada/444/2004 share high sequence identity and 
differ in their HA cleavage site by one amino acid (Hirst et al., 2004), and the H7N8 viruses 
A/turkey/Indiana/1403/2016 and A/turkey/Indiana/1573-2/2016 differ by only eight amino 
acids and a three basic residue insertion in the HA cleavage site (Sun et al., 2016a). As 
shown in Table 1, we observed no pronounced difference in murine infectivity between 
either pair of viruses (76% and 83% infectivity between H7N3 HPAI and LPAI viruses and 
11% and 0% infectivity between H7N8 HPAI and LPAI viruses, respectively), further 
supporting a noncritical role for chicken virulence classification and cleavage site 
composition in mammalian ocular infectivity (Belser et al., 2009b; Sun et al., 2016a).
3.3. Contribution of internal genes to ocular infectivity
Despite the elevated frequency of infection following ocular inoculation with H7 viruses 
compared with non-H7 viruses, the presence of an H7 HA alone is not sufficient to confer an 
ocular tropism in mice or humans (Belser et al., 2013c). As such, it is likely that internal 
virus genes contribute to this property. To more specifically address this question, we 
examined the infectivity of reassortant influenza viruses possessing surface glycoproteins 
from wild-type influenza viruses with all internal genes derived from A/Puerto Rico/8/1934 
(PR/8), a laboratory-adapted H1N1 virus found not to infect mice by the ocular route (Table 
3). Infectivity in mice by the ocular route was maintained despite replacing the internal 
genes of the H7N9 LPAI virus A/Anhui/1/2013, at 86% (following wild-type virus infection, 
Table 1) and 80% (following PR/8 reassortant virus infection, Table 3). In support of this 
finding, an additional H7N9 PR/8 reassortant virus tested, bearing surface glycoproteins 
from A/Shanghai/2/2013 virus, exhibited 100% infectivity in mice by the ocular route (Table 
3). However, replacing the internal genes of the H7N3 HPAI virus A/Mexico/
InDRE7218/2012 was sufficient to abrogate virus infectivity by the ocular route in mice, 
from 94% (following wild-type virus infection, Table 1), to 0% (following PR/8 reassortant 
virus infection, Table 3). These findings indicate that internal genes likely contribute to 
ocular tropism in a strain-specific manner.
The amino acid position at 627 in PB2 has been identified as a molecular determinant of 
host range and virulence for influenza viruses, including H7 subtype viruses (Munster et al., 
2007; Subbarao et al., 1993). Many H5N1 and H7N9 influenza viruses associated with 
human infection contain an E627K mutation in PB2 and possess enhanced virulence in small 
mammalian models (mouse and ferret), in contrast with many ocular-tropic H7 subtype 
viruses associated with human infection, which generally retain a glutamic acid at position 
627 (Fouchier et al., 2004). To examine the role of this amino acid in murine ocular 
infectivity, we compared the risk of infection following ocular inoculation between viruses 
with a lysine and those with a glutamic acid residue at this position (Fig. 2). Among all 
viruses identified in Table 1, 627K was associated with a significantly higher risk of 
infection in mice compared with 627E (64% vs 37% respectively, p < 0.001). When viruses 
were separated by subtype, 627K was associated with a higher risk of infection for both H7 
and non-H7 viruses (p < 0.002 for both, Fig. 2A and B). This association was maintained 
when H7 subtype viruses were separated into H7N9-only and non-H7N9 groups, indicating 
that the association between 627K and increased risk of infection was not confounded by the 
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presence of several 627K-bearing-bearing H7N9 viruses in our analysis (data not shown). 
Interestingly, this analysis revealed that while both 627K and 627E H7 subtype viruses were 
associated with murine infection following ocular inoculation, only non-H7 subtype viruses 
possessing a lysine at position 627 were associated with murine infection (Fig. 2B). This 
suggests that the residue at position 627 may have a greater influence on the ability of non-
H7 viruses to infect via the ocular route compared to H7 viruses. However, logistic 
regression did not find the interaction between having an H7 HA and PB2 627K significant, 
likely due to the low power of this analysis.
3.4. Subtype-specific tropism following ocular inoculation
Due in part to replication-independent drainage of virus from the eye to nasopharyngeal 
space, influenza virus can be detected in both ocular and respiratory tract tissues following 
ocular inoculation (Belser et al., 2012a). After finding that H7 subtype viruses are 
statistically more likely to cause infection in mice following ocular inoculation compared 
with H5 viruses, we next investigated more specifically the frequency in which infectious 
virus is detected in the eye, nose, and lung of mice inoculated by the ocular route with 
ocular-tropic (H7 subtype) or respiratory-tropic (H5 subtype) influenza viruses. Among 
mice that were infected following ocular inoculation with either wild-type H5 or H7 subtype 
viruses, we found that H7 subtype viruses were significantly more likely to be detected in 
the eye or nose through day 6 p.i. than were H5 subtype viruses (p < 0.001 and p < 0.01, 
respectively), with > 70% of H7 virus-infected mice possessing detectable virus in both 
tissues (75% and 72%, respectively) (Fig. 3). In contrast, mice infected with H5 viruses 
more frequently possessed detectable virus in the nose (61%) than eye (26%), mirroring the 
respiratory tropism of this subtype in humans. Rates of virus detection in the lung were not 
significantly different between these virus subtypes (41% and 35% for H7 and H5 subtype 
viruses, respectively). Viral titers detected in these samples were generally low ( < 3 log10 
PFU or EID50/ml) independent of virus subtype (data not shown), suggesting that this 
murine model of ocular inoculation is most suitable for examining frequency of detection of 
infectious virus, rather than the magnitude of the detected titer. These analyses reveal that 
H7 subtype viruses not only infect mice at a higher rate following ocular inoculation than 
other virus subtypes, but also indicate that they are more likely to replicate in ocular tissue 
during the acute phase of infection.
4. Discussion
H7 subtype influenza viruses typically exhibit an ocular tropism in humans, causing 
conjunctivitis with or without associated respiratory involvement. In this regard, influenza 
virus is similar to other principal respiratory viruses (such as respiratory syncytial virus and 
adenovirus), for which a particular subtype or subgroup appears to possess a non-respiratory 
tropism. There is a poor understanding of what contributes to the non-respiratory tropism of 
all of these viruses (Belser et al., 2013c). Well-characterized laboratory models which 
recapitulate a tropism detected in humans represent an essential tool to elucidate the viral 
and host factors which confer this property. Our study identifies murine ocular inoculation as 
the only mammalian model characterized to date which mirrors the apparent ocular tropism 
associated with H7 virus subtype infection in humans.
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Murine models for ocular inoculation and ocular infection have been characterized for 
several respiratory pathogens (Belser et al., 2013c). Despite the utility of these models to 
study ocular exposure to virus, these species do not fully emulate the ocular disease 
observed in humans. In particular, while conjunctivitis is the most frequently reported ocular 
complication associated with influenza virus infection, neither mice nor ferrets typically 
display macroscopic signs of conjunctivitis. While the lack of clinical presentation of ocular 
symptoms limits our full capacity to study the ocular tropism of selected respiratory viruses, 
these models nonetheless provide the ability to better understand the capacity and propensity 
for ocular infection and ocular replication.
Epithelia of the human cornea and surrounding conjunctiva bear a predominance of α2–3 
linked sialic acids (the cellular receptor preferred by most avian influenza viruses), and a 
paucity of α2–6 linked sialic acids (preferred by most human influenza viruses) (Kumlin et 
al., 2008). Thus, it has been postulated that avian influenza viruses may be better suited to 
infecting the α2–3-rich ocular environment (Olofsson et al., 2005). However, we showed 
previously via virus immunohistochemistry that both human and avian influenza viruses can 
attach to murine corneal tissue, and further demonstrated productive virus replication of both 
H5 and H7 influenza viruses in excised murine whole corneas or corneal epithelial sheets 
(Belser et al., 2009b). Furthermore, many H5N1 viruses tested that exhibit strong binding to 
α2–3 sialosides were not capable of causing robust infection following ocular inoculation in 
mice (including A/Hong Kong/486/1997 and A/Indonesia/5/2005) (Belser et al., 2009b; 
Stevens et al., 2008), whereas H7 subtype viruses with both strict α2–3 (including A/
Netherlands/219/2003) and mixed α2–3/α2–6 (including A/Canada/504/2004) binding 
properties demonstrated a high capacity for infectivity following ocular exposure (Belser et 
al., 2008). While receptor-binding differences may yet contribute to ocular infectivity, these 
data suggest that an α2–3 binding preference alone is insufficient to confer an ocular 
tropism to a virus which otherwise does not possess this capacity. Further detailed 
characterization of the human ocular surface, especially with regard to sialoside composition 
and density, is needed, as is a greater understanding of conjunctivitis and/or other ocular 
complications following human exposure to avian compared with human influenza viruses.
We found that among H7N3, H7N7, and H7N9 viruses, murine infectivity following ocular 
inoculation was independent of neuraminidase pairing or virus lineage. However, it is 
important to note that in these two specific analyses, H7N2 and H7N8 pairings were 
excluded due to low representation (n=2 unique viruses for each) and diversity in our 
dataset. It is unclear if the lack of infectivity detected among these viruses (North American 
avian isolates from 2002–3 [H7N2] or 2016 [H7N8]) following ocular inoculation in mice is 
truly representative of these HA-NA combinations or rather a reflection of poor diversity in 
available viruses to include for this analysis and lack of Eurasian lineage viruses to include 
for comparison. It should be noted that Eurasian lineage, but not North American lineage 
H7N2 viruses, have been associated with ocular disease in humans (Belser et al., 2009a). 
Further investigation of these viruses, as well as other H7 HA-NA pairings causing poultry 
outbreaks (such as H7N1) will permit a greater understanding of the propensity for ocular 
disease.
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H7 subtype influenza viruses associated with ocular disease in humans represent a wide 
range of heterogeneity, including variance within the neuraminidase subtype, virus lineage, 
and pathotype. Notably, H7 viruses associated with human conjunctivitis have acquired a 
HPAI phenotype by the traditional insertion of multiple basic amino acids at the HA 
cleavage site, or by nonhomologous recombination with other viral gene segments or host 
ribosomal RNA (Hirst et al., 2004; Lopez-Martinez et al., 2013; Pasick et al., 2005), 
underscoring a diversity of cleavage site compositions. However, H7 LPAI viruses bearing a 
single basic amino acid at the HA cleavage site have also been associated with ocular 
disease in humans and murine ocular infection (Belser et al., 2009a). To further support that 
ocular tropism is not affected by cleavage site, we found that H7N9-PR8 reassortant viruses, 
but not H5N1-PR8 reassortant viruses, for which the multibasic amino acid cleavage site 
was removed to match the single arginine cleavage site composition of H7N9 viruses, were 
infectious following ocular inoculation in mice (Table 3). Collectively, this study confirms 
that intrinsic properties of the H7 hemagglutinin, independent of cleavage site, confer an 
enhanced ability to infect following ocular exposure in mammals.
Compared with other H7 viruses, H7N9 influenza viruses associated with human infection 
more closely resemble H5N1 viruses with regard to their respiratory tropism, elicitation of 
innate host responses, and capacity to cause severe respiratory disease in humans (Chan et 
al., 2013; Zeng et al., 2015). Despite an absence of ocular tropism with this virus subtype, 
H7N9 viruses from 2013 to 2015 nonetheless appear to possess the capacity for murine 
infectivity following ocular inoculation (Fig. 1), and have been detected in ocular secretions 
from intranasally inoculated mice (Bao et al., 2014). It is currently unclear what governs this 
altered tissue tropism of H7N9 viruses in humans. Previous study has identified a synergistic 
role for both HA and NA genes from a 2009 H1N1 virus in conferring conjunctival tropism 
in vitro (Chan et al., 2011), identifying a need to further study in additional laboratory 
models the role N9 neuraminidase may have in influencing this property.
The role of internal genes in the ocular tropism of H7 influenza viruses is not clear, and 
represents an area of much-needed research. Our finding that the surface glycoproteins are 
not sufficient to maintain the infectivity of an H7N3 HPAI virus by the ocular route (Table 3) 
identifies a potential role for internal proteins in this property, warranting further study to 
identify the specific gene(s) responsible for this result. It is possible that the replication 
advantage among H7N9 and H5N1 viruses bearing E627K in PB2, demonstrated in both 
avian and mammalian cells (Yamayoshi et al., 2015; Zhang et al., 2014), permits enhanced 
infectivity by the ocular route in mice. H7N7 and H5N1 viruses bearing the 627K 
substitution have replicated to higher titer than 627E-bearing viruses in human corneal and 
conjunctival cells in vitro (Belser et al., 2011b). However, studies identifying that an E627K 
mutation alone do not uniformly confer higher growth rates and virulence in mammalian 
models, and our finding that H7 subtype viruses bearing either 627E and 627K can infect 
mice following ocular inoculation (Fig. 2), suggests that this substitution alone is neither 
necessary nor sufficient (Zhu et al., 2010). Clearly, there remains a need for a better 
understanding of molecular determinants of non-respiratory tropism of influenza virus.
The human eye is a complex organ, with several tissue components exposed to the 
environment and thus susceptible to exposure to virus infection by aerosol or fomites. As no 
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one mammalian model or in vitro system can fully recapitulate the diversity of the human 
ocular milieu, the study of complex virus-host interactions at the ocular surface poses an 
ongoing challenge in the laboratory. The murine model of ocular inoculation described here 
currently represents the most stringent in vivo model available to study the ocular tropism 
possessed by H7 subtype viruses. The use of models such as this has permitted the 
investigation of antiviral drugs to mitigate viral replication and spread following H7 ocular 
exposure (Belser et al., 2012b), underscoring the need for well-characterized mammalian 
models to examine the diversity of influenza virus exposure routes and disease presentations.
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Fig. 1. 
Risk of murine infection following ocular inoculation with influenza virus. Mice were 
inoculated by the ocular route with influenza viruses shown in Table 1 and separated into 
“infected” or “not infected” groups based on detection of infectious virus in the eye, nose, or 
lung through day 6 p.i. (limit of virus detection, 100.8 EID50/ml or 10 PFU/ml). Error bars 
represent 99% confidence intervals. A, risk of murine infection between all influenza viruses 
listed in Table 1 bearing an H7 hemagglutinin (18 viruses) and viruses bearing a non-H7 
hemagglutinin (16 viruses) (p < 0.001). B, risk of murine infection between influenza 
viruses bearing the surface glycoproteins shown (4 H7N3, 3 H7N7, 7 H7N9, 6 H5N1, 2 
H3N2, 8 H1N1 viruses), statistical information provided in Table 2. C, risk of murine 
infection between North American lineage (9 viruses; n=61 inoculated mice) or Eurasian 
lineage (9 viruses; n=84 inoculated mice) H7N3, H7N7, and H7N9 viruses (p > 0.01). D, 
risk of murine infectivity between H7 HPAI (6 viruses; n=84 inoculated mice) or LPAI (12 
viruses; n=92 inoculated mice) influenza viruses listed in Table 1 (p > 0.01).
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Fig. 2. 
Contribution of PB2 627 to risk of murine infection following ocular inoculation with 
influenza virus. Mice were inoculated by the ocular route with influenza viruses shown in 
Table 1 and separated into “infected” or “not infected” groups based on detection of 
infectious virus in the eye, nose, or lung through day 6 p.i. (limit of virus detection, 100.8 
EID50/ml or 10 PFU/ml). Error bars represent 99% confidence intervals. Relative risk of 
murine infection between influenza viruses bearing a lysine (K) or glutamic acid (E) at 
position 627 among A, all H7 viruses (6 627K viruses, n=60 inoculated mice; 12 627E 
viruses, n=116 inoculated mice) or B, non-H7 viruses (9 627K viruses, n=70 inoculated 
mice; 7 627E viruses, n=46 inoculated mice), p < 0.002 for both comparisons.
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Fig. 3. 
Differential detection of infectious virus following ocular inoculation in mice. Mice were 
inoculated by the ocular route with H5 and H7 subtype influenza viruses shown in Table 1. 
The risk of positive virus detection in the eye, nose, or lung through day 6 p.i. based on virus 
subtype is shown (limit of virus detection, 100.8 EID50/ml or 10 PFU/ml). Error bars 
represent 99% confidence intervals. H5: 6 viruses, n=23 inoculated mice per tissue. H7: 18 
viruses, n=114 (eye) or 116 (nose, lung) inoculated mice. Statistical significance between 
H7 and H5 subtype viruses is p < 0.001 (eye), p < 0.01 (nose), p > 0.01 (lung).
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